Beta Alanine Exercise Recovery Randomized Trial: What the Evidence Says

Quick Answer

Beta Alanine Exercise Recovery Randomized Trial has 3 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial, 1 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Importantly, mechanistic evidence indicates that performance loss during repeated maximal efforts reflects an integrated disturbance in muscle function-encompassing substrate availability, metabolite/ionic perturbations, excitation-contraction coupling, and only later, more pronounced acid-base disruption-rather than a single dominant metabolite (-). [Liang Weibao (2026); evidence level 1]
• Consistent with this mechanism, contemporary meta-analytic evidence indicates the most reproducible ergogenic effects in high-intensity exercise tasks of approximately 1-4 min, where acid-base perturbation is more likely to be performance-limiting. [Liang Weibao (2026); evidence level 1]
• Similarly, no between-roup differences were found for height (= 0.21, = 0.839, = 0.07,rivial effect), BMI (= −0.97, = 0.340, = −0.35, small effec), or body fat percentae (= −1.20, = 0.242, = −0.44, small effec). [Küçük Furkan Hasan (2026); evidence level 2]
• Table 3 (26) (26) (26) (26) As shown in, no significant between-group differences were found in baseline physical performance variables (all p > 0.05). [Küçük Furkan Hasan (2026); evidence level 2]
• Consequently, there is a lack of evidence-based medical evidence for the treatment of HFpEF. [Huang Rufeng (2026); evidence level 2]
• But increasing clinical studies have found that SGLT2i can confer cardiovascular benefits to patients with HFpEF. [Huang Rufeng (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For beta alanine exercise recovery randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Liang Weibao (2026). No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1818755. PMCID: PMC13061858. PMID: 41971372. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13061858/
• Küçük Furkan Hasan (2026). Effects of β-alanine supplementation on kickboxing-specific anaerobic performance, neuromuscular power, and strength endurance: A randomized, double-blind, placebo-controlled trial. DOI: 10.1371/journal.pone.0346898. PMCID: PMC13170865. PMID: 42127019. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13170865/
• Huang Rufeng (2026). Empagliflozin in improving exercise tolerance in HFpEF: study protocol for an open-label, randomized controlled study. DOI: 10.1186/s13063-026-09654-y. PMCID: PMC13188374. PMID: 41947187. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13188374/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.